Contact this trialFirst, we need to learn more about you.
Antibody Drug Conjugate
Gemtuzumab Ozogamicin + Donor Leukocytes for Acute Myeloid Leukemia
Recruiting1 awardPhase 2
Providence, Rhode Island
This trial is testing whether the drug Gemtuzumab Ozogamicin, followed by an infusion of blood cells called leukocytes from a donor, can stimulate the immune system to potentially fight the leukemia.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service